Next Article in Journal
‘Sustainable’ Rather Than ‘Subsistence’ Food Assistance Solutions to Food Insecurity: South Australian Recipients’ Perspectives on Traditional and Social Enterprise Models
Previous Article in Journal
Erratum: Assari, S.; Mistry, R. Educational Attainment and Smoking Status in a National Sample of American Adults; Evidence for the Blacks’ Diminished Return. Int. J. Environ. Res. Public Health 2018, 15, 763
Previous Article in Special Issue
The Importance of Using Public Health Impact Criteria to Develop Environmental Health Indicators: The Example of the Indoor Environment in New Zealand
Open AccessArticle

Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population

Flemish Institute for Technological Research (VITO)—Sustainable Health, 2400 Mol, Belgium
German Environment Agency (UBA), 14195 Berlin, Germany
Department of Chemistry and Applied Biosciences, Eidgenössische Technische Hochschule (ETH), 8092 Zürich, Switzerland
Research Centre for Toxic Compounds in the Environment (RECETOX), Masaryk University, 611 37 Brno, Czech Republic
Institute of Risk Assessment Sciences (IRAS), Utrecht University, 3508 TC Utrecht, The Netherlands
Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
Institute of Environmental Medicine (IMM), Karolinska Institutet (KI), 171 77 Stockholm, Sweden
European Environment Agency (EEA), 1050 Copenhagen, Denmark
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2018, 15(10), 2085;
Received: 3 August 2018 / Revised: 14 September 2018 / Accepted: 17 September 2018 / Published: 21 September 2018
(This article belongs to the Special Issue Environmental Health Indicators for Policy Support)
The European Union’s 7th Environmental Action Programme (EAP) aims to assess and minimize environmental health risks from the use of hazardous chemicals by 2020. From this angle, policy questions like whether an implemented policy to reduce chemical exposure has had an effect over time, whether the health of people in specific regions or subpopulations is at risk, or whether the body burden of chemical substances (the internal exposure) varies with, for example, time, country, sex, age, or socio-economic status, need to be answered. Indicators can help to synthesize complex scientific information into a few key descriptors with the purpose of providing an answer to a non-expert audience. Human biomonitoring (HBM) indicators at the European Union (EU) level are unfortunately lacking. Within the Horizon2020 European Human Biomonitoring project HBM4EU, an approach to develop European HBM indicators was worked out. To learn from and ensure interoperability with other European indicators, 15 experts from the HBM4EU project (German Umweltbundesamt (UBA), Flemish research institute VITO, University of Antwerp, European Environment Agency (EEA)), and the World Health Organization (WHO), European Core Health Indicator initiative (ECHI), Eurostat, Swiss ETH Zurich and the Czech environmental institute CENIA, and contributed to a workshop, held in June 2017 at the EEA in Copenhagen. First, selection criteria were defined to evaluate when and if results of internal chemical exposure measured by HBM, need to be translated into a European HBM-based indicator. Two main aspects are the HBM indicator’s relevance for policy, society, health, and the quality of the biomarker data (availability, comparability, ease of interpretation). Secondly, an approach for the calculation of the indicators was designed. Two types of indicators were proposed: ‘sum indicators of internal exposure’ derived directly from HBM biomarker concentrations and ‘indicators for health risk’, comparing HBM concentrations to HBM health-based guidance values (HBM HBGVs). In the latter case, both the percentage of the studied population exceeding the HBM HBGVs (PE) and the extent of exceedance (EE), calculated as the population’s exposure level divided by the HBM HBGV, can be calculated. These indicators were applied to two examples of hazardous chemicals: bisphenol A (BPA) and per- and polyfluoroalkyl substances (PFASs), which both have high policy and societal relevance and for which high quality published data were available (DEMOCOPHES, Swedish monitoring campaign). European HBM indicators help to summarize internal exposure to chemical substances among the European population and communicate to what degree environmental policies are successful in keeping internal exposures sufficiently low. The main aim of HBM indicators is to allow follow-up of chemical safety in Europe. View Full-Text
Keywords: indicator; human biomonitoring; HBM; science-policy translation; HBM4EU; health-based guidance value; groups of substances indicator; human biomonitoring; HBM; science-policy translation; HBM4EU; health-based guidance value; groups of substances
Show Figures

Figure 1

MDPI and ACS Style

Buekers, J.; David, M.; Koppen, G.; Bessems, J.; Scheringer, M.; Lebret, E.; Sarigiannis, D.; Kolossa-Gehring, M.; Berglund, M.; Schoeters, G.; Trier, X. Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population. Int. J. Environ. Res. Public Health 2018, 15, 2085.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop